Antisoma Share Discussion Threads

[cumnor] 25/3/2011 07:29

Because, I suspect, ora intend to plough ahead with their original plan to use the cash and listing to refocus on somthing else, as they have sucessfully elsewhere. The rns has the feel of, along with cost cutting which is going to plan, a further clearing of the decks for further news and clarifying the situation in light of ongoing redundancies. Imo dyor

[the_doctor] 25/3/2011 07:06

Offer over...

so, why were certain insts buying so much of this? I dont get it (yet)

[dahmmy] 15/3/2011 14:34

dying

buy into sar and pyc, once things get clearer here buy back in..

[clubman] 12/3/2011 16:59

Expect a large fall of stock's, and indices on Monday due to the Japenese situation.

[freddie ferret] 10/3/2011 15:28

Sacking most of your staff and cutting your own throat in under 2 months is quite good going. To see who is running the company see the RNSs.

[jsbach123] 10/3/2011 14:15

Errr freddie ...decisive?... Edwards has already resigned (and left?) - in fact little management of ASM left so not sure how they are being decisive. Fairly obvious that with failed product portfolio you dont need a team of professionals to administer and publicise it. In fact do we know who is running what is left of the company?

[freddie ferret] 09/3/2011 15:59

I said that the management of ASM were decisive, todays RNS shows how they are cutting costs, having already dispensed with most of the board. Interesting to see what they have planned, watch this space.




9 March 2011, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that it has undertaken a substantial reduction in staff numbers
in accordance with the announcement on 8 February that the Company would take
steps to conserve its cash resources.

Total headcount has now been reduced to around 10 staff and will fall further
next month. The following members of the Senior Management Team have left or
will shortly be leaving the Company: Gary Acton (Chief Medical Officer),
Nicholas Adams (VP, Business Development), Michael Boss (General Manager,
Autoimmune), Daniel Elger (VP, Marketing and Communications), Sharon Grimster
(VP, Regulatory, Pharmaceutical and Business Operations) and Chris Smyth (VP,
Clinical Operations).

[leedskier] 09/3/2011 10:31

A listed company on AIM has some intrinsic value. The ideal solution would be a reverse take-over at a fair price reflecting that value and the cash.

[filbert3] 03/3/2011 17:07

I said it was my opinion - your opinion clearly differs as it appears you think that ASM have assets of value which have not been revealed to the world - unlikely in my view.

What they have is a basket of failed drugs and the IP associated with those. Of little value, in my view. Best to just give the cash back.

[freddie ferret] 03/3/2011 16:24

You ignore the IP Filbert. You also think you know it all. At the present things are uncertain, we simply do not know what offers have been made if any, what the assets are and who may want them, whether therr are other products to be developed.

[filbert3] 02/3/2011 18:01

freddie ferret

I don't see what you mean by your 'bomb' analogy - in my view shutting up shop and giving the cash back to shareholders is the best thing to do.

[loverat] 02/3/2011 17:35

What utter rubbish and a ridiculous analogy. Clearly an opinion which would have been apparent to most.

He could have chosen his words more carefully but this is a bulletin board for heaven sake.

[freddie ferret] 02/3/2011 17:26

Anyway I am quite happy the company seems to be cutting their expenses which is what they said they were going to do, thus the cash pile will last longer and allows them the leeway to do deals.

[freddie ferret] 02/3/2011 17:24

Filbert3.
If you phone in a bogus bomb warning to the police saying there seems to be a bomb at so and so a place, I think you would still be in trouble even if you prefaced it with "seems".

[filbert3] 02/3/2011 17:14

freddie ferret

"Seems" - ie my opinion - that's my opinion of what's going on - feel free to have another opinion if you like. I predict the company will be wound up and any remaining cash returned to shareholders, this strategy probably driven by ORA.

[freddie ferret] 02/3/2011 15:17

Post 5656 was a post for the OXB thread I have removed it and placed it where is should be Loverat, no need to get confused is there.

[loverat] 02/3/2011 14:25

FF

Is someone posting in invisible ink?


Who are you talking to?

[freddie ferret] 02/3/2011 14:03

Actually dramatic steps are being taken to cut costs. Glynn Edwards said steps would be taken to cut the cost of the board and it would seem they are being taken. It would be interesting to know what staff cuts are being undertaken if any.

[freddie ferret] 02/3/2011 13:57

Sorry wrong thread.

[filbert3] 02/3/2011 13:18

Soon to be wound up to return the remaining cash to shareholders - seems that ORA are forcing such a strategy through with their 110m shareholding and insistence on a board seat (and getting rid of the failed management).